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Purpose: To develop a simple, cheap, fast, accurate, sensitive and precise colorimetric 
method that can be used for the determination of chloramphenicol. 
Method: Chloramphenicol was reduced in a mixture of glacial acetic acid and water using 
titanium (III) chloride at room temperature within 10 min. The reduced product was then 
heated for 20 min with p-dimethylaminobenzaldehyde to yield the final product whose 
absorbance was used for the determination of the concentration of chloramphenicol. Results 
obtained with this method were compared with those obtained with the microbiological assay 
of chloramphenicol. 
Result: The final product of the two step reaction was greenish – yellow in colour,, absorbed 
strongly in the visible region and obeyed Beer’s law at max  = 440 nm. The method developed 
was sensitive and accurately determined chloramphenicol in the presence of common 
excipients and in different dosage forms. There was statistically no significant difference (p < 
0.05) between the results with the method developed and those obtained with the 
microbiological assay of chloramphenicol. 
Conclusion: A simple, fast, cheap, precise, sensitive and accurate colorimetric method has 
been developed that could be routinely used for the determination of chloramphenicol in bulk 
drug and in different dosage forms. The advantage of the method is its speed and simplicity. 
 
Key words: Chloramphenicol, colorimetric assay, microbiological assay, p-dimethyl-
aminobenzaldehyde. 
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Introduction 
 
Chloramphenicol is one of the first widely 
used antibiotics.  It was discovered in 1947 
by Ehrlich et al1 amongst the metabolic 
products of Streptomyces venezuelae. The 
ability of chloramphenicol to inhibit 
rickettsiae in-vitro as well as a wide range of 
gram-positive and gram-negative bacteria 
gave rise to its immediate interest. This 
interest was further enhanced when the 
antibiotic was found to be well absorbed 
from the alimentary tracts of mice and dog1. 
It is bacteriostatic for most organisms but 
bacteriacidal to Haemophilus influencae.  
 
Chloramphenicol acts by interfering with 
protein synthesis specifically by inhibiting the 
enzyme that transfers the peptide chain to 
the amino acid (puromycin) on the 
ribosome2.  Recently, it has been shown that 
the drug causes single–strand breaks in 
Escherichia coli deoxyribonucleic acid3, 4. 
 
Chloramphenicol is commercially available in 
different dosage forms and can be 
administered as capsule, injection, eye drops 
and ear drops. Various methods are 
available for the assay of the compound in 
bulk drug, in dosage forms and in biological 
fluids5-20. These include colorimetric5-8, 
microbiological9-11, radio-immunoassay12, 13, 
high performance liquid chromatography14-17, 
gas liquid chromatography18, spectro-
photometric19, 20, and polarographic21 
methods.  
 
Although various colorimetric methods are 
available for the assay of the compound, 
they often lack speed and the experimental 
conditions are cumbersome and are thus 
prone to errors.  The objective of the present 
work is to develop an alternative colorimetric 
method for the routine assay of 
chloramphenicol in bulk drug and dosage 
forms.  This method is simple, fast, cheap, 






All the reagents were of analytical grade and 
were used as received.  Para-dimethylamino 
benzaldehyde and methanol were obtained 
from BDH Chemical Limited (Poole, United 
Kingdom). Titanium (III) chloride (14.5 – 
15.5%), glacial acetic acid and dimethyl 
sulphoxide  were obtained from May and 
Baker (Dagenham, United Kingdom). 
Nutrient agar was obtained from Oxoid 
Limited (Bassingstoke, United Kingdom).  
Pure sample of chloramphenicol powder was 
obtained from Parke Davis Medical (East 
Leigh Hants, United Kingdom).  Five different 
brands of chloramphenicol capsules, five 
brands of chloramphenicol injections, four 
brands of chloramphenicol eye drops and 
four brands of chloramphenicol ear drops 
were purchased from local pharmacies in 
Benin City, Nigeria.   
 
The equipments used include a Spectronic 
D21 ultra – violet/visible spectrophotometer 
(Milton Roy Limited, USA), steam bath, 
shaker bath, hot box oven, autoclave and 







Pure chloramphenicol powder (0.1 g) was 
accurately weighed into a 20 ml volumetric 
flask containing a mixture of 3 ml each of 
glacial acetic acid and distilled water.  The 
contents of the flask were shaken gently to 
dissolve the powder.  Titanium (III) chloride  
(3 ml) was then added to the flask and the 
contents mixed gently.  The mixture was left 
to stand at room temperature for 10 min to 
achieve complete reduction of the nitro 
group of chloramphenicol to a primary 
aromatic amino group. The resulting solution 
(1 ml) was then pipetted into a 25 ml 
volumetric flask and made up to volume with 
methanol.  From this solution, 0.2, 0.4, 0.6, 
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0.8 and 1.0 ml was each pipetted into 
different 25 ml volumetric flasks.  The 
content of each flask was made up to 1.0 ml 
by adding 0.8, 0.6, 0.4, 0.2 and 0.0 ml of 
methanol, respectively. Para–dimethyl-
aminobenzaldehyde (10 ml of 0.1% w/v in 
methanol) was then added to each flask.  
The contents were mixed and heated on a 
steam bath for 20 min.  The flasks were 
brought out, allowed to cool to room 
temperature and each made up to volume 
with methanol. Blank was obtained by 
repeating the procedure but omitting the 
drug in the preparations. Time for the 
completion of each of the two reactions i.e. 
the reduction and the reaction with para– 
dimethylaminobenzaldehyde were noted.  
The wavelength of maximum absorption 
(λmax) of the product of reaction was also 
noted.  
 
Stability of the final product was investigated 
by measuring the absorbance of the final 
product at λmax at 0.5, 1.0, 2.0, 3.0 and 4.0 hr 
after its formation. To test the sensitivity, 
reproducibility and limit of detection of the 
method developed, various standards of 
chloramphenicol were prepared. The 
concentrations of chloramphenicol in the 
final solutions of these standards ranged 
from 3.6 to 17.8 g/ml. The limit of detection 
was taken as twice the minimum 
concentration that could be determined 
reproducibly and falling in the linear portion 
of a regression line of a range of 
concentrations of the compound. To 
investigate the effects of starch and lactose, 
0.2 g of each was separately mixed with 0.1 
g of chloramphenicol.  Each mixture was 
used in the place of the drug in the 
procedure above.  For capsule and injection 
dosage forms, the weights of granules and 
powders respectively equivalent to 0.1 g of 
chloramphenicol were quickly weighed and 
used in the place of pure chloramphenicol in 
the procedure above.  For chloramphenicol 
eye and ear drops, 2.0 ml of each eye and 
ear drop was added to a mixture of 3.0 ml 
glacial acetic acid and 1.0 ml of distilled 
water.  The procedure was then continued 
as for the pure drug above.  A Beer’s plot 
was made at the wavelength of maximum 
absorption from where the concentrations of 




The method outlined in the British 
Pharmacopoeia19 was adopted. 
Chloramphenicol solution (5 mg/ml) was 
made in dimethyl sulphoxide and diluted with 
distilled water to produce a 1 mg/ml solution. 
This solution was diluted serially with distilled 
water to produce different standard solutions 
containing 30, 60, 90 and 120 µg/ml of 
chloramphenicol.  An overnight broth culture 
of Sarcina lutea (ATOC 9341) obtained from 
the Department of Pharmaceutical 
Microbiology, University of Benin, Benin City 
was used in inoculating the surface of five 
nutrient agar plates.  A sterile 4 mm cork 
borer was used to make wells in the agar 
plates. The standard chloramphenicol 
solutions (0.4 ml each) were placed into the 
wells. Dimethyl sulphoxide (without the drug) 
diluted serially as above was used as control 
and 0.4 ml was also placed inside the well.  
The plates were maintained at room 
temperature for 30 min to allow diffusion of 
the drug into the medium and incubated at 
37° C for 24 hr. The diameter of the zones of 
inhibition was then measured. Readings 
were done in duplicate and their averages 
taken. 
 
For capsule and injection dosage forms, their 
granules and powders respectively were 
used to prepare solutions equivalent to 5 
mg/ml chloramphenicol in dimethyl 
sulphoxide.  Thereafter, the procedure for 
the pure drug was followed.  For the eye and 
ear drops, 1.0 ml was taken and added to 
9.0 ml of dimethyl sulphoxide. This was 
mixed and diluted further with dimethyl 
sulphoxide to produce a solution equivalent 
to 5 mg/ml chloramphenicol. Each was then 
diluted serially with dimethyl sulphoxide to 
make different standard solutions and the 
procedure for the pure-drugs followed.  A 
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semi–logarithmic plot of logarithm of 
concentration versus average diameter of 
zone of inhibition was made from where 
concentrations of unknowns were 
interpolated. 
 
Analysis of data 
 
A statistical package called Instat (GraphPad 
Inc, USA) was used to compare the results 
obtained from the method developed and the 
microbiological assay of chloramphenicol for 
various dosage forms using 2-tailed paired 
Student t-test. At 95% confidence interval, 2-
tailed p – values less than 0.05 were 




The procedure used in obtaining the 
final product involved two separate 
reactions. These are the initial 
reduction of the aromatic nitro group in 
chloramphenicol to a primary aromatic 
amine which in turn was reacted with 
p–dimethylaminobenzaldehyde. By 
withdrawing samples after different 
times of reduction, we established that 
the reduction of the nitro group in 
chloramphenicol using titanium (III) 
chloride under the experimental 
condition adopted here, reached 
completion in less than 10 min.  We 
also established that 10 ml of 0.1 % 
w/v p–dimethylaminobenzaldehyde in 
methanol added to the reduction 
product and heated for 20 min was the 
optimum condition for the quantitative 
yield of the final product.  The final 
product was greenish-yellow in colour 
and had a wavelength of maximum 
absorption (λmax) of 440 nm. At this 
wavelength, and under the 
experimental conditions followed here, 
Beer’s law was obeyed for 
chloramphenicol reaction product. The 
regression equation of absorbance as 
a function of the concentration of 
chloramphenicol in the final product is 
A = 0.0074 + 0.054C (r2 = 0.9995) 
where A is absorbance, C is concentration in 
µg/ml and r is correlation coefficient. Limit of 
detection was found to be 1.05 µg/ml. 
Coefficients of variation ranged from 0.61 to 
2.17% at a concentration range of 1.05 
µg/ml to 17.8 µg/ml. The excipients (lactose 
and starch) in the capsules did not interfere 
with the assay of chloramphenicol using this 
method developed. Recoveries of 
chloramphenicol from lactose and starch 
were 98.8 ± 0.6% and 97.9 ± 0.1 %, 
respectively. 
 
Results of the assay of chloramphenicol in 
the different dosage forms using both the 
method developed and microbiological 
method are shown in the Table. We found no 
statistical difference between the method 
 
Table: Percentage of label claim of chloramphenicol in 

















99.69 ± 1.05 
11.42 ± 0.18 
99.71 ± 1.04 
98.98 ± 0.95 
98.70 ± 0.96 
 
101.66 ± 0.68 
11.84 ± 0.34 
101.93 ± 0.83 
101.06 ± 0.96 















99.58 ± 1.08 
98.83 ± 0.24 
98.80 ± 0.90 
98.98 ± 0.95 
99.51 ± 0.62 
 
99.83 ± 1.26 
100.28 ± 1.21 
101.38 ± 0.83 
101 05 ± 0.96 
















99.96 ± 0.90 
99.27 ± 0.87 
99.42 ± 0.89 
98.41 ± 0.53 
 
99.88 ± 1.13 
100.82 ± 1.23 
100.49 ± 0.74 















99.58 ± 0.71 
99.40 ± 0.80 
98.41 ± 0.97 
99.90 ± 0.49 
 
 
100.90 ± 1.03 
100.53 ± 1.18 
100.49 ± 0.74 
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We have developed an alternative 
colorimetric method in this study for the 
determination of chloramphenicol. This 
method is a modification of the method of 
Glazko and Wolf5 which involves the 
reduction of the nitro group in 
chloramphenicol with potassium borohydride 
in alkaline medium containing palladium and 
reacting the primary aromatic amine 
produced with p–dimethylamino benzal-
dehyde to give a coloured product. The 
method of Glazko and Wolf5 is associated 
with problems including (1) the reducing 
agent is not very soluble in the medium used 
necessitating filtration to be carried out after 
the reduction process, and (2) the reaction is 
not quantitative. Titanium (III) chloride in 
glacial acetic acid chosen as the reducing 
agent of the nitro group of chloramphenicol 
in this study has been known to reduce 
aromatic and heter–aromatic nitro groups 
easily and quantitatively at room 
temperature22.  This reduction process is 













To ensure that the reaction proceeded 
favourably to the right, the amount of water 
must be minimised.  The initial medium of 
equal volumes of glacial acetic acid : water 
(1:1 v/v) has been established to be the 
optimum condition for aromatic nitro group 
reduction22. Thus by simply mixing 
chloramphenicol and titanium (III) chloride in 
the solvent system, the reduction took place 
easily at room temperature within 10 min.  
Prolonged reaction time at high temperature 
was avoided for the reduction. Colour 
development was achieved with p- 
dimethylaminobenzaldehyde as it reacted 
with the reduced chloramphenicol to form a 



























The reaction product contained an extensive 
conjugated double bond (chromophore) that 
absorbed in the visible region of the 
electromagnetic spectrum (λmax = 440 nm).  
Water is also a product of this reaction and 
should be minimised for product formation to 
proceed quantitatively. Use of methanol at all 
stages of the reaction minimised the amount 
of available water and also ensured that the 
products of the reactions dissolved easily. 
 
Under the experimental conditions adopted, 
Beer’s law was obeyed for different 
concentrations of chloramphenicol; thus 
each stage of the reaction was quantitative.  
At the wavelength of maximum absorption of 
the reaction product, 1.05 µg/ml of 
chloramphenicol gave an absorbance value 
of 0.05. Thus, the method is very sensitive. 
Also, the final product was stable for over 4 
hr. The reactions took place homogeneously, 
and can be easily carried out.  Of particular 
note is the reduction reaction which took 
place quickly at room temperature.  
 
When applied to assay chloramphenicol in 
different dosage forms, the method 
developed was found to be very precise. 
Assay results of chloramphenicol in all the 
different dosage forms investigated (except 
one brand of chloramphenicol capsule) met 
the requirements of chloramphenicol in the 
different dosage forms in respect of the 
percentage label claim19.  Both the method 
developed and microbiological method 
proved that one of the products investigated 
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was substandard with content of 
chloramphenicol being 11.4 and 11.8%, 
respectively. At 95% confidence interval, no 
significant difference was found between the 
data obtained using the method developed 
and the microbiological method.  
 
Chloramphenicol has been determined 
colorimetrically using vanillin for colour 
development of the reduced 
chloramphenocol23. A rapid and simple 
enzymatic assay of chloramphenicol has 
been developed which combined the 
specificity of the enzyme chloramphenicol 
acetyltransferase with the convenience of 
colorimetric detection24. The assay of 
chloramphenicol using this method was 
linear over the concentration range of 1.5 – 
65 g/ml. The linear range of the method 
developed in this study falls within this 
range. Colorimetric detection after high 
pressure liquid chromatography has also 
been used to study the pharmacokinetics of 
chloramphenicol in cows after intramuscular 
application and to monitor the levels of 
chloramphenicol in the blood and milk of 
goats following oral administration25, 26. The 
method developed here can thus facilitate 
the colorimetric detection of chloramphenicol 




An alternative colorimetric method has been 
developed that is very fast, sensitive, 
reproducible, simple and cheap to carry out 
yet gave accurate results.  The developed 
method can be used for the routine assay of 
chloramphenicol in bulk drug and in 
pharmaceutical dosage forms.  
 
The colour development in the final product 
involved the reaction of p-dimethyl-
aminobenzaldehyde and the primary 
aromatic amine of reduced chloramphenicol. 
Any trace of primary aromatic amine in the 
reaction system will thus interfere in the 
colour development and hence affect the 
final result. In order to make this method 
specific for chloramphenicol, it is 
recommended that it should be extracted 
first or that any product that will yield any 
primary aromatic amine in the reaction 
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